| 1 |
Batool S, Sohail S, Ud Din F, Alamri AH, Alqahtani AS, Alshahrani MA, Alshehri MA, Choi HG. A detailed insight of the tumor targeting using nanocarrier drug delivery system. Drug Deliv 2023;30:2183815. [PMID: 36866455 DOI: 10.1080/10717544.2023.2183815] [Reference Citation Analysis]
|
| 2 |
Azad AK, Ping NY, Hasnain MS, Nayak AK. Application of nanotheranostics in cancer. Design and Applications of Theranostic Nanomedicines 2023. [DOI: 10.1016/b978-0-323-89953-6.00004-0] [Reference Citation Analysis]
|
| 3 |
Shahriar SMS, Andrabi SM, Islam F, An JM, Schindler SJ, Matis MP, Lee DY, Lee YK. Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment. Pharmaceutics 2022;14. [PMID: 36559206 DOI: 10.3390/pharmaceutics14122712] [Reference Citation Analysis]
|
| 4 |
Aventaggiato M, Barreca F, Sansone L, Pellegrini L, Russo MA, Cordani M, Tafani M. Sirtuins and Hypoxia in EMT Control. Pharmaceuticals (Basel) 2022;15:737. [PMID: 35745656 DOI: 10.3390/ph15060737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Naziris N, Demetzos C. Lipid Nanoparticles as Platforms for Theranostic Purposes: Recent Advances in the Field. JNT 2022;3:86-101. [DOI: 10.3390/jnt3020006] [Reference Citation Analysis]
|
| 6 |
Berehu HM, Anupriya S, Patnaik S. Nanotechnology-Based Therapeutics in ROS-Induced Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_254] [Reference Citation Analysis]
|
| 7 |
Berehu HM, Anupriya S, Patnaik S. Nanotechnology-Based Therapeutics in ROS-Induced Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_254-2] [Reference Citation Analysis]
|
| 8 |
Javed MN, Akhter MH, Taleuzzaman M, Faiyazudin M, Alam MS. Cationic nanoparticles for treatment of neurological diseases. Fundamentals of Bionanomaterials 2022. [DOI: 10.1016/b978-0-12-824147-9.00010-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Ferreira (Noronha) N, Cancino-bernardi J, Cardoso VMDO, Comparetti EJ, Miranda RR, Ferreira LMB, Zucolotto V. Smart systems in bio-encapsulation for cancer therapy. Smart Nanomaterials for Bioencapsulation 2022. [DOI: 10.1016/b978-0-323-91229-7.00015-5] [Reference Citation Analysis]
|
| 10 |
Berehu HM, Anupriya S, Patnaik S. Nanotechnology-Based Therapeutics in ROS-Induced Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_254-1] [Reference Citation Analysis]
|
| 11 |
Zhu R, Lang T, Yin Q, Li Y. Nano drug delivery systems improve metastatic breast cancer therapy. Medical Review 2021;1:244-274. [DOI: 10.1515/mr-2021-0011] [Reference Citation Analysis]
|
| 12 |
Rizwanullah M, Ahmad MZ, Ghoneim MM, Alshehri S, Imam SS, Md S, Alhakamy NA, Jain K, Ahmad J. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics 2021;13:2039. [PMID: 34959321 DOI: 10.3390/pharmaceutics13122039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Baker A, Khan MS, Iqbal MZ, Khan MS. Tumor-targeted Drug Delivery by Nanocomposites. Curr Drug Metab 2020;21:599-613. [PMID: 32433002 DOI: 10.2174/1389200221666200520092333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 14 |
Zhao J, Zhao Y, Ma X, Zhang B, Feng H. Targeting ferroptosis in osteosarcoma. J Bone Oncol 2021;30:100380. [PMID: 34345580 DOI: 10.1016/j.jbo.2021.100380] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Bukhari SI, Imam SS, Ahmad MZ, Vuddanda PR, Alshehri S, Mahdi WA, Ahmad J. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges. Pharmaceutics 2021;13:840. [PMID: 34200251 DOI: 10.3390/pharmaceutics13060840] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 16 |
Rizwanullah M, Ahmad MZ, Garg A, Ahmad J. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochim Biophys Acta Gen Subj 2021;1865:129936. [PMID: 34058266 DOI: 10.1016/j.bbagen.2021.129936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Höltke C, Grewer M, Stölting M, Geyer C, Wildgruber M, Helfen A. Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution. Mol Pharm 2021;18:2574-85. [PMID: 34048242 DOI: 10.1021/acs.molpharmaceut.1c00064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 18 |
Sabir F, Qindeel M, Zeeshan M, Ul Ain Q, Rahdar A, Barani M, González E, Aboudzadeh MA. Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes 2021;9:621. [DOI: 10.3390/pr9040621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 19 |
Gilani SJ, Bin-jumah M, Rizwanullah M, Imam SS, Imtiyaz K, Alshehri S, Rizvi MMA. Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells. Coatings 2021;11:158. [DOI: 10.3390/coatings11020158] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 20 |
Mohapatra A, Uthaman S, Park IK. External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy. Front Mol Biosci 2020;7:597634. [PMID: 33505987 DOI: 10.3389/fmolb.2020.597634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 21 |
Ahmad MZ, Rizwanullah M, Ahmad J, Alasmary MY, Akhter MH, Abdel-wahab BA, Warsi MH, Haque A. Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2020.1869737] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 22 |
Fakhri KU, Sultan A, Mushtaque M, Hasan MR, Nafees S, Hafeez ZB, Zafaryab M, Rizwanullah M, Sharma D, Bano F, Almalki WH, Ahmad FJ, Rizvi MMA. Obstructions in Nanoparticles Conveyance, Nano-Drug Retention, and EPR Effect in Cancer Therapies. Handbook of Research on Advancements in Cancer Therapeutics 2021. [DOI: 10.4018/978-1-7998-6530-8.ch026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Alshehri S, Imam SS, Rizwanullah M, Akhter S, Mahdi W, Kazi M, Ahmad J. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges. Pharmaceutics 2020;13:E24. [PMID: 33374391 DOI: 10.3390/pharmaceutics13010024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 24 |
Akhter MH, Rizwanullah M, Ahmad J, Amin S, Ahmad MZ, Minhaj MA, Mujtaba MA, Ali J. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme. Drug Res (Stuttg) 2021;71:122-37. [DOI: 10.1055/a-1296-7870] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 25 |
Yadav KS, Upadhya A, Misra A. Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers). Expert Opin Drug Deliv 2021;18:103-18. [PMID: 33017541 DOI: 10.1080/17425247.2021.1832989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 26 |
Singh G, Nenavathu BP, Imtiyaz K, Moshahid A Rizvi M. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity. Biomed Pharmacother 2020;129:110443. [PMID: 32593130 DOI: 10.1016/j.biopha.2020.110443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 27 |
Beg S, Barkat MA, Ahmad FJ. Advancement in Polymer and Lipid-based Nanotherapeutics for Cancer Drug Targeting. Curr Pharm Des 2020;26:1127. [PMID: 32349650 DOI: 10.2174/138161282611200424113756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
